Amgen (AMGN) PT Raised to $332 at Morgan Stanley

May 1, 2026 9:13 AM

Morgan Stanley analyst Terance Flynn raised the price target on Amgen (NASDAQ: AMGN) to $332.00 (from $326.00) while maintaining a Equalweight rating.

No results found